{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:23:04Z","timestamp":1781259784821,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12028-025-02225-0","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:24:05Z","timestamp":1741098245000},"page":"392-402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anticoagulant Therapy for Cerebral Venous Sinus Thrombosis: A Propensity Score Matching Study and Inverse Probability Weighting"],"prefix":"10.1007","volume":"43","author":[{"given":"Kai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8089-1250","authenticated-orcid":false,"given":"Yuming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"9","key":"2225_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrneurol.2017.104","volume":"13","author":"SM Silvis","year":"2017","unstructured":"Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555\u201365. https:\/\/doi.org\/10.1038\/nrneurol.2017.104.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2225_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000509802","volume":"83","author":"PS Idiculla","year":"2020","unstructured":"Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E. Cerebral venous thrombosis: a comprehensive review. Eur Neurol. 2020;83(4):369\u201379. https:\/\/doi.org\/10.1159\/000509802.","journal-title":"Eur Neurol"},{"issue":"1","key":"2225_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.blre.2014.09.006","volume":"29","author":"SE Thorell","year":"2015","unstructured":"Thorell SE, Parry-Jones AR, Punter M, Hurford R, Thachil J. Cerebral venous thrombosis-a primer for the haematologist. Blood Rev. 2015;29(1):45\u201350. https:\/\/doi.org\/10.1016\/j.blre.2014.09.006.","journal-title":"Blood Rev"},{"issue":"3","key":"2225_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/01.str.30.3.484","volume":"30","author":"SF de Bruijn","year":"1999","unstructured":"de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30(3):484\u20138. https:\/\/doi.org\/10.1161\/01.str.30.3.484.","journal-title":"Stroke"},{"issue":"8767","key":"2225_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0140-6736(91)90607-q","volume":"338","author":"KM Einh\u00e4upl","year":"1991","unstructured":"Einh\u00e4upl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis [published correction appears in Lancet 1991 Oct 12;338(8772):958]. Lancet. 1991;338(8767):597\u2013600. https:\/\/doi.org\/10.1016\/0140-6736(91)90607-q.","journal-title":"Lancet"},{"issue":"8","key":"2225_CR6","doi-asserted-by":"publisher","first-page":"CD002005","DOI":"10.1002\/14651858.CD002005.pub2","volume":"2011","author":"J Coutinho","year":"2011","unstructured":"Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev. 2011;2011(8):CD002005. https:\/\/doi.org\/10.1002\/14651858.CD002005.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2225_CR7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","volume":"42","author":"G Saposnik","year":"2011","unstructured":"Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42(4):1158\u201392. https:\/\/doi.org\/10.1161\/STR.0b013e31820a8364.","journal-title":"Stroke"},{"issue":"10","key":"2225_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/ene.13381","volume":"24","author":"JM Ferro","year":"2017","unstructured":"Ferro JM, Bousser MG, Canh\u00e3o P, et al. European Stroke Organization. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis-endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203\u201313.","journal-title":"Eur J Neurol"},{"issue":"11","key":"2225_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.7326\/0003-4819-139-11-200312020-00007","volume":"139","author":"LA Linkins","year":"2003","unstructured":"Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med. 2003;139(11):893\u2013900. https:\/\/doi.org\/10.7326\/0003-4819-139-11-200312020-00007.","journal-title":"Ann Intern Med"},{"issue":"11","key":"2225_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.7326\/M18-1523","volume":"169","author":"A Lowenstern","year":"2018","unstructured":"Lowenstern A, Al-Khatib SM, Sharan L, et al. Interventions for preventing thromboembolic events in patients with atrial fibrillation: a systematic review. Ann Intern Med. 2018;169(11):774\u201387. https:\/\/doi.org\/10.7326\/M18-1523.","journal-title":"Ann Intern Med"},{"key":"2225_CR11","doi-asserted-by":"publisher","unstructured":"Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report [published correction appears in Chest. 2016 Oct;150(4):988. https:\/\/doi.org\/10.1016\/j.chest.2016.08.1442]. Chest. 2016;149(2):315\u2013352. https:\/\/doi.org\/10.1016\/j.chest.2015.11.026","DOI":"10.1016\/j.chest.2016.08.1442"},{"issue":"6","key":"2225_CR12","doi-asserted-by":"publisher","first-page":"21m02927","DOI":"10.4088\/PCC.21m02927","volume":"23","author":"R Shahid","year":"2021","unstructured":"Shahid R, Zafar A, Nazish S, et al. An observational study comparing the safety and efficacy of conventional anticoagulation versus new oral anticoagulants in the management of cerebral venous sinus thrombosis. Prim Care Companion CNS Disord. 2021;23(6):21m02927. https:\/\/doi.org\/10.4088\/PCC.21m02927.","journal-title":"Prim Care Companion CNS Disord."},{"key":"2225_CR13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1001\/jamaneurol.2019.2764","volume":"76","author":"JM Ferro","year":"2019","unstructured":"Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canh\u00e3o P, Karpov D, Nagel S, Posthuma L, Roriz JM, et al. RE-SPECT CVT Study Group. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMANeurol. 2019;76:1457\u201365. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2764.","journal-title":"JAMANeurol."},{"issue":"11","key":"2225_CR14","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1161\/STROKEAHA.123.044113","volume":"54","author":"TS Field","year":"2023","unstructured":"Field TS, Dizonno V, Almekhlafi MA, et al. Study of rivaroxaban for cerebral venous thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-care in symptomatic cerebral venous thrombosis. Stroke. 2023;54(11):2724\u201336. https:\/\/doi.org\/10.1161\/STROKEAHA.123.044113.","journal-title":"Stroke"},{"issue":"7","key":"2225_CR15","doi-asserted-by":"publisher","first-page":"e64744","DOI":"10.7759\/cureus.64744","volume":"16","author":"S Nirhale","year":"2024","unstructured":"Nirhale S, Rohatgi S, Rao P, Naphade P, Hatekar KS. Study of use of dabigatran in cerebral venous sinus thrombosis. Cureus. 2024;16(7):e64744. https:\/\/doi.org\/10.7759\/cureus.64744.","journal-title":"Cureus."},{"issue":"2","key":"2225_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12028-018-0628-3","volume":"30","author":"K Liu","year":"2019","unstructured":"Liu K, Pei L, Gao Y, et al. Dehydration status predicts short-term and long-term outcomes in patients with cerebral venous thrombosis. Neurocrit Care. 2019;30(2):478\u201383. https:\/\/doi.org\/10.1007\/s12028-018-0628-3.","journal-title":"Neurocrit Care"},{"issue":"3","key":"2225_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12028-018-0544-6","volume":"29","author":"K Liu","year":"2018","unstructured":"Liu K, Song B, Gao Y, et al. Long-term outcomes in patients with anemia and cerebral venous thrombosis. Neurocrit Care. 2018;29(3):463\u20138. https:\/\/doi.org\/10.1007\/s12028-018-0544-6.","journal-title":"Neurocrit Care"},{"issue":"3","key":"2225_CR18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/STROKEAHA.121.037541","volume":"53","author":"S Yaghi","year":"2022","unstructured":"Yaghi S, Shu L, Bakradze E, et al. Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study. Stroke. 2022;53(3):728\u201338. https:\/\/doi.org\/10.1161\/STROKEAHA.121.037541.","journal-title":"Stroke"},{"issue":"4","key":"2225_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000151678","volume":"26","author":"KF Huybrechts","year":"2008","unstructured":"Huybrechts KF, Caro JJ, Xenakis JJ, Vemmos KN. The prognostic value of the modified Rankin Scale score for long-term survival after first-ever stroke. Results from the Athens Stroke Registry. Cerebrovasc Dis. 2008;26(4):381\u20137. https:\/\/doi.org\/10.1159\/000151678.","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"2225_CR20","first-page":"1","volume":"3","author":"AI Qureshi","year":"2010","unstructured":"Qureshi AI. A classification scheme for assessing recanalization and collateral formation following cerebral venous thrombosis. J Vasc Interv Neurol. 2010;3(1):1\u20132.","journal-title":"J Vasc Interv Neurol"},{"issue":"10","key":"2225_CR21","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1161\/STROKEAHA.122.039579","volume":"53","author":"S Yaghi","year":"2022","unstructured":"Yaghi S, Saldanha IJ, Misquith C, et al. Direct oral anticoagulants versus vitamin K antagonists in cerebral venous thrombosis: a systematic review and meta-analysis. Stroke. 2022;53(10):3014\u201324. https:\/\/doi.org\/10.1161\/STROKEAHA.122.039579.","journal-title":"Stroke"},{"issue":"1","key":"2225_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10194-023-01562-9","volume":"24","author":"Z Wang","year":"2023","unstructured":"Wang Z, Dandu C, Guo Y, et al. A novel score to estimate thrombus burden and predict intracranial hypertension in cerebral venous sinus thrombosis. J Headache Pain. 2023;24(1):29. https:\/\/doi.org\/10.1186\/s10194-023-01562-9.","journal-title":"J Headache Pain"},{"key":"2225_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/ene.12901","volume":"23","author":"C Herweh","year":"2016","unstructured":"Herweh C, Griebe M, Geisb\u00fcsch C, Szabo K, Neumaier-Probst E, Hennerici MG, Bendszus M, Ringleb PA, Nagel S. Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis. Eur J Neurol. 2016;23:681\u20137. https:\/\/doi.org\/10.1111\/ene.12901.","journal-title":"Eur J Neurol"},{"issue":"3","key":"2225_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.18502\/cjn.v20i3.7687","volume":"20","author":"F Khorvash","year":"2021","unstructured":"Khorvash F, Farajpour-Khanaposhtani MJ, Hemasian H, Saadatnia SM. Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: a case-control blinded study. Curr J Neurol. 2021;20(3):125\u201330. https:\/\/doi.org\/10.18502\/cjn.v20i3.7687.","journal-title":"Curr J Neurol"},{"issue":"3","key":"2225_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/jnnp-2014-310068","volume":"87","author":"A Arauz","year":"2016","unstructured":"Arauz A, Vargas-Gonz\u00e1lez JC, Arguelles-Morales N, et al. Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy. J Neurol Neurosurg Psychiatry. 2016;87(3):247\u201351. https:\/\/doi.org\/10.1136\/jnnp-2014-310068.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"2225_CR26","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/jamaneurol.2020.1022","volume":"77","author":"JM Coutinho","year":"2020","unstructured":"Coutinho JM, Zuurbier SM, Bousser MG, et al. Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: the TO-ACT randomized clinical trial. JAMA Neurol. 2020;77(8):966\u201373. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1022.","journal-title":"JAMA Neurol"}],"updated-by":[{"DOI":"10.1007\/s12028-025-02267-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000}}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-025-02225-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T14:23:34Z","timestamp":1757946214000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-025-02225-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2225"],"URL":"https:\/\/doi.org\/10.1007\/s12028-025-02225-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12028-025-02267-4","asserted-by":"object"}]},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated to correct the author line to remove the secondary affiliation \"The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China\" for authors Mengmeng Zhang and Qinqin Dai.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12028-025-02267-4","URL":"https:\/\/doi.org\/10.1007\/s12028-025-02267-4","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The human studies were subjected to rigorous ethical review and approval by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University. The patients\/participants involved in the study provided their written informed consent, indicating their willingness to participate in the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/informed consent"}}]}}